Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Braun

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Expert Opinion on Investigational Drugs|October 26, 2021
Derazantinib: an investigational drug for the treatment of cholangiocarcinomaStephan Braun, Paul McSheehy, Karine Litherland, et al.
Cancer Discovery|May 13, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal CancerRodrigo Dienstmann, Amita Patnaik, Rocio Garcia-Carbonero, et al.
The New England Journal of Medicine|August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancerStephan Braun, Florian D Vogl, Bjørn Naume, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Expert Opinion on Investigational Drugs|October 26, 2021
Derazantinib: an investigational drug for the treatment of cholangiocarcinomaStephan Braun, Paul McSheehy, Karine Litherland, et al.
Cancer Discovery|May 13, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal CancerRodrigo Dienstmann, Amita Patnaik, Rocio Garcia-Carbonero, et al.
The New England Journal of Medicine|August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancerStephan Braun, Florian D Vogl, Bjørn Naume, et al.
Pageof 4